Metformin may help the immune system better identify breast cancer cells

byUniversity of HelsinkiCredit: Unsplash/CC0 Public DomainMetformin is a widely prescribed drug for managing type 2 diabetes. In recent years, indications of its potential anticancer properties

Updated on: April 28,2024

Metformin may help the immune system better identify breast cancer cells

byUniversity of HelsinkiCredit: Unsplash/CC0 Public DomainMetformin is a widely prescribed drug for managing type 2 diabetes. In recent years, indications of its potential anticancer properties

Updated on:April 28,2024

Study: Antiretroviral therapy crucial in preventing non-Hodgkin lymphoma

by Michael Greenwood,Yale UniversityHIV infecting a human cell. Credit: NIHA research team led by the Yale School of Public Health has found that for people living with HIV/AIDS, both recent imm

Updated on: June 28,2024

Study: Antiretroviral therapy crucial in preventing non-Hodgkin lymphoma

by Michael Greenwood,Yale UniversityHIV infecting a human cell. Credit: NIHA research team led by the Yale School of Public Health has found that for people living with HIV/AIDS, both recent imm

Updated on:June 28,2024

Study finds non-Hodgkins lymphoma treatment also targets related forms of lymphoma

by Hudson Institute of Medical ResearchHelicobacter-infected Nlrc5mø-KOmice develop precursor lesions to gastric B-cell MALT lymphoma. Representative H&E-stained sections of gastric tis

Updated on: February 23,2024

Study finds non-Hodgkins lymphoma treatment also targets related forms of lymphoma

by Hudson Institute of Medical ResearchHelicobacter-infected Nlrc5mø-KOmice develop precursor lesions to gastric B-cell MALT lymphoma. Representative H&E-stained sections of gastric tis

Updated on:February 23,2024

Cancer drug restores immune system's ability to fight tumors

by University of Texas at AustinCredit: Pixabay/CC0 Public DomainA new, bio-inspired drug restores the effectiveness of immune cells in fighting cancer, a team led by researchers at The Universit

Updated on: March 06,2024

Cancer drug restores immune system's ability to fight tumors

by University of Texas at AustinCredit: Pixabay/CC0 Public DomainA new, bio-inspired drug restores the effectiveness of immune cells in fighting cancer, a team led by researchers at The Universit

Updated on:March 06,2024

Researchers demonstrate technique for identifying single cancer cells in blood for the first time

byKeele UniversityBrightfield image of a cytospun sample containing PBMC and individual CALU-1 cancer cells. Credit:PLOS ONE(2023). DOI: 10.1371/journal.pone.0289824A pioneering stud

Updated on: March 30,2024

Researchers demonstrate technique for identifying single cancer cells in blood for the first time

byKeele UniversityBrightfield image of a cytospun sample containing PBMC and individual CALU-1 cancer cells. Credit:PLOS ONE(2023). DOI: 10.1371/journal.pone.0289824A pioneering stud

Updated on:March 30,2024

132-pound tumor removed from woman's abdomen

In this February 2018 photograph provided by the Danbury Hospital, a large tumor is prepared to be removed from a patient at the hospital in Danbury, Conn. Doctors removed the 132-pound tumor from a w

Updated on: March 08,2024

132-pound tumor removed from woman's abdomen

In this February 2018 photograph provided by the Danbury Hospital, a large tumor is prepared to be removed from a patient at the hospital in Danbury, Conn. Doctors removed the 132-pound tumor from a w

Updated on:March 08,2024

Genomic screening can help detect thyroid cancer, finds study

byGeisinger Health SystemCredit: Pixabay/CC0 Public DomainPopulation-based genomic screening can facilitate early detection of medullary thyroid cancer (MTC) in patients with variants in the RET

Updated on: January 23,2024

Genomic screening can help detect thyroid cancer, finds study

byGeisinger Health SystemCredit: Pixabay/CC0 Public DomainPopulation-based genomic screening can facilitate early detection of medullary thyroid cancer (MTC) in patients with variants in the RET

Updated on:January 23,2024

Allogenic hematopoietic cell transplant a viable option for high-risk myelodysplastic syndrome, study suggests

byDana-Farber Cancer InstituteClinical outcomes by TP53 allelic state. (A) OS by TP53 allelic state. (B) Cumulative incidence of MDS relapse or progression to AML by TP53 allelic state, with dea

Updated on: January 16,2024

Allogenic hematopoietic cell transplant a viable option for high-risk myelodysplastic syndrome, study suggests

byDana-Farber Cancer InstituteClinical outcomes by TP53 allelic state. (A) OS by TP53 allelic state. (B) Cumulative incidence of MDS relapse or progression to AML by TP53 allelic state, with dea

Updated on:January 16,2024

A new targeted treatment shows promise for select patients with stomach cancer

byWeill Cornell Medical CollegeCredit: Pixabay/CC0 Public DomainAn international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, has found tha

Updated on: January 29,2024

A new targeted treatment shows promise for select patients with stomach cancer

byWeill Cornell Medical CollegeCredit: Pixabay/CC0 Public DomainAn international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, has found tha

Updated on:January 29,2024

Novel immunotherapy agent safe, shows promise against high-risk prostate cancers

byJohns Hopkins University School of MedicinePatient consort diagram and efficacy outcomes in the neoadjuvant treatment of patients with PCa using enoblituzumab. Credit:Nature Medicine&nbs

Updated on: January 15,2024

Novel immunotherapy agent safe, shows promise against high-risk prostate cancers

byJohns Hopkins University School of MedicinePatient consort diagram and efficacy outcomes in the neoadjuvant treatment of patients with PCa using enoblituzumab. Credit:Nature Medicine&nbs

Updated on:January 15,2024

New study unveils epigenetic 'traffic lights' controlling stop and go for gene activity

by Institute of Cancer ResearchAcute depletion of SET1/COMPASS core subunits reveals rapid turnover of H3K4me3.a, Schematic of the degron systems for the targeted degradation of DPY30 and R

Updated on: February 23,2024

New study unveils epigenetic 'traffic lights' controlling stop and go for gene activity

by Institute of Cancer ResearchAcute depletion of SET1/COMPASS core subunits reveals rapid turnover of H3K4me3.a, Schematic of the degron systems for the targeted degradation of DPY30 and R

Updated on:February 23,2024

Drug combo breaks down cancer resistance to immunotherapy

by Ecole Polytechnique Federale de LausanneA schematic summary of the study. Credit: Douglas Hanahan (EPFL)Immunotherapy is a way of treating cancer by reprogramming the patient's immune syst

Updated on: February 23,2024

Drug combo breaks down cancer resistance to immunotherapy

by Ecole Polytechnique Federale de LausanneA schematic summary of the study. Credit: Douglas Hanahan (EPFL)Immunotherapy is a way of treating cancer by reprogramming the patient's immune syst

Updated on:February 23,2024